Lijing Zhu

2 articles listing Lijing Zhu in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial Nature Communications
2. Mesothelin-directed protein-drug conjugates for mesothelin-low solid tumor therapy Nature Communications